Covaris provides tools and technologies to improve pre-analytical sample preparation, enable novel drug formulations, and manage compounds in the drug discovery process.

The Covaris technological foundation is based on its proprietary and patented AFA» technology. AFA enables a vast array of non-contact, isothermal processes to be developed for use in a broad range of applications in Genomics, Proteomics, Cell Biology and Drug Discovery, and Formulation. Thousands of Focused-ultrasonicators are in use in over 30 countries and customers include the worldÍs leading researchers, universities, and pharmaceutical companies.